Parnax Lab Ltd. (PARNAXLAB): Parnax Lab Share Price Rises 9.84% Today on Rs 134 Close

Published: 28 August 2026 at 3:18:46 PM IST

Parnax Lab Share Price was higher today, with the stock closing at Rs 134 after a 9.84% rise from the previous close of Rs 122. The company’s market capitalisation stands at Rs 140.76 Cr, placing the move in the context of a relatively modest listed value rather than a broad market heavyweight. Par nax Lab Share Price Today is therefore a notable share price rise within today’s Stock Market Today session, even though the supplied data does not establish a company-specific catalyst. The move also drew attention in Parnax Lab Stock News because the day’s range was broad, the turnover stood at Rs 0.01 Cr, and the healthcare setting gives the update clear sector relevance for Indian Stock Market watchers following Stocks in News and Top Gainers Today.

The verified data confirms the event, the price path and the valuation backdrop. It does not establish why the stock moved. Investors tracking Parnax Lab Share Price News can therefore focus on what is measurable today: the open at Rs 128.9, the intraday high of Rs 140 and the low of Rs 117.5, alongside the current price, turnover and market cap. Univest frames this as a factual market update rather than a narrative about cause. For readers following Parnax Lab Share Price Live, the next useful reference points are the company’s fundamentals, healthcare sector comparison and the broader list of pharma peers supplied below.

Parnax Lab Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 134
Previous Close	Rs 122
Today's Move	Rs 12 (+9.84%)
Open	Rs 128.9
High	Rs 140
Low	Rs 117.5
Turnover	Rs 0.01 crore
Market Capitalisation	Rs 140.76 crore
Market Cap Category	Micro Cap

Parnax Lab Ltd. (PARNAXLAB) rose to Rs 134 from the previous close of Rs 122, a move of Rs 12 or 9.84%. The stock opened at Rs 128.9, reached a high of Rs 140, recorded a low of Rs 117.5.

Parnax Lab Share Price Today moved from Rs 122 at the previous close to Rs 134, adding Rs 12 during the session. The stock opened at Rs 128.9, touched an intraday high of Rs 140 and a low of Rs 117.5, which shows that the price moved within a wide daily band before settling higher. The turnover recorded was Rs 0.01 Cr, and the day’s change of 9.84% places Parnax Lab among the sharper gainers in today’s market update. This is the clearest factual explanation available in the supplied data for Parnax Lab Share Price and Parnax Lab Share Price Rise.

For readers searching Parnax Lab News Today, the important point is simple: the session ended well above the previous close, but the verified data does not attach a company-specific reason to the rise. Univest therefore treats this as a price rise first and a context-driven stock update second. That keeps the analysis grounded in what the numbers actually show.

Parnax Lab Ltd. (PARNAXLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 140.76 crore
P/E Ratio	15.68x
P/B Ratio	1.47x
ROE	14.92%
ROCE	14.71%
EPS	Rs 7.78
Book Value Per Share	Rs 83.2
Dividend Yield	0%

Parnax Lab Ltd. (PARNAXLAB) fundamental metrics show P/E 15.68x, P/B 1.47x, ROE 14.92%, ROCE 14.71%. These figures provide context only and are not a buy or sell signal.

Parnax Lab Ltd. has a market capitalisation of Rs 140.76 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 15.68x, P/B at 1.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.92% and ROCE of 14.71%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 7.78, book value per share of Rs 83.2, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.16x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	15.68x
Benchmark Median P/E	31.16x
Benchmark Average P/E	48.05x
Benchmark P/E Range	3.36x to 397.25x
Company P/B Ratio	1.47x
Benchmark Median P/B	2.71x
Company ROE	14.92%
Benchmark Median ROE	11.82%
Company ROCE	14.71%
Benchmark Median ROCE	13.71%
Company Market Capitalisation	Rs 140.76 crore
Benchmark Median Market Cap	Rs 664.09 crore

Parnax Lab Ltd. (PARNAXLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Parnax Lab Ltd. (PARNAXLAB) has a P/E ratio of 15.68x, which is below the benchmark median of 31.16x, a difference of -49.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Parnax Lab Ltd. (PARNAXLAB) has a ROE of 14.92%, which is above the benchmark median of 11.82%, a difference of +26.23%. Parnax Lab Ltd. (PARNAXLAB) has a ROCE of 14.71%, which is above the benchmark median of 13.71%, a difference of +7.29%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,56,113.58	37.7	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,39,321.25	82.14	13.6	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,85,923.81	87.64	21.3	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,508.45	26.28	4.4	19.69	21.39
Cipla Ltd.	CIPLA	1,13,778.04	34.03	3.26	11.83	16

Parnax Lab Ltd. (PARNAXLAB) has a P/E ratio of 15.68x compared with the displayed peer median of 37.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Parnax Lab Ltd. (PARNAXLAB) has a market capitalisation of Rs 140.76 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Parnax Lab

• Parnax Lab Share Price rose 9.84% today and closed at Rs 134, compared with Rs 122 at the previous close.
• The session range was Rs 117.5 to Rs 140, which gives clear day-specific context to the Parnax Lab Share Price Today move.
• Market capitalisation stands at Rs 140.76 Cr, which keeps the company’s size visible in any Parnax Lab Stock News update.
• P/E of 15.68, P/B of 1.47, ROE of 14.92% and ROCE of 14.71% provide the core Parnax Lab Fundamental Analysis backdrop.
• In the healthcare sector benchmark, the company’s P/E and P/B are below the median, while ROE and ROCE are above or close to the benchmark averages.

About Parnax Lab

Parnax Lab Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not give a detailed product or revenue-mix breakdown, so the company profile here stays anchored to verified market classification and financial metrics. What can be stated clearly is that the stock is listed on the Indian market, carries a market capitalisation of Rs 140.76 Cr and is being tracked through Parnax Lab Share Price News because of today’s rise. The business context is therefore best understood through its listed-sector identity, valuation ratios and return metrics rather than broader operating claims. For readers comparing Parnax Lab Share Price Today with other pharma names, Univest keeps the focus on the facts that are available: market cap, earnings-based valuation, return ratios and the current session’s price action. That makes the article a practical reference point for both Parnax Lab Stock Analysis and Parnax Lab Latest News tracking.

Track Parnax Lab Share Price on Univest

Use Parnax Lab Ltd. (PARNAXLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Parnax Lab Share Price on Univest for live market updates, valuation ratios, shareholding pattern, 52-week levels and company insights. The platform also helps compare Parnax Lab Stock News with sector and peer data in one place. Univest brings together Parnax Lab Share Price Today, fundamental analysis, market cap context and stock performance history so that the headline move can be reviewed alongside the company’s broader profile.

Frequently Asked Questions

Why is Parnax Lab Share Price rising today?

Ans. The supplied data confirms that Parnax Lab Share Price rose 9.84% today, but it does not identify a company-specific catalyst. The session closed at Rs 134 after opening at Rs 128.9 and touching Rs 140.

What is the current Parnax Lab Share Price?

Ans. Parnax Lab Share Price is Rs 134. It is up Rs 12, or 9.84%, from the previous close of Rs 122, and the company’s market capitalisation stands at Rs 140.76 Cr.

How much did Parnax Lab stock move today?

Ans. Parnax Lab stock moved up Rs 12 in the session, which is a 9.84% rise. The day’s range ran from Rs 117.5 to Rs 140, showing a wide price movement before the close.

What does Parnax Lab Fundamental Analysis show?

Ans. Parnax Lab Fundamental Analysis shows a P/E of 15.68, P/B of 1.47, ROE of 14.92%, ROCE of 14.71%, EPS of Rs 7.78 and book value of Rs 83.2. Dividend yield is 0.

How does Parnax Lab compare with healthcare peers?

Ans. Compared with supplied pharma peers, Parnax Lab Share Price reflects a far smaller market cap and lower P/E and P/B ratios. Its ROE is ahead of several large peers, while ROCE is broadly competitive.

What sector does Parnax Lab belong to?

Ans. Parnax Lab belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark covers 201 companies in the same industry, which makes the valuation comparison more meaningful.

Does Parnax Lab Share Price have a dividend yield?

Ans. The supplied dividend yield for Parnax Lab is 0. That means the current Parnax Lab Share Price update is driven by valuation, earnings and return metrics rather than an income payout measure.